ResMed | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
Ansell USD 326.2M 27.6M 2024-06
AtriCure USD 101.48M 8.85M 2025-06
Baxter International USD 1.14B 283M 2025-06
Cochlear AUD 881.7M 14.5M 2024-12
Cooper Companies USD 679.1M 18.9M 2025-04
CSL USD 4.28B 939M 2024-12
Dexcom USD 688.8M 99.8M 2025-06
Edwards Lifesciences USD 1.19B 76.7M 2025-06
Fisher Paykel Healthcare NZD 588.7M 30.4M 2024-09
Globus Medical USD 1.21B 809.01M 2025-06
Haemonetics USD 192.24M 806K 2025-06
Hologic USD 576.6M 15.9M 2025-06
Idexx Laboratories USD 694.73M 71.35M 2025-06
Insulet USD 452.2M 43.2M 2025-06
Integra LifeSciences USD 209.33M 5.81M 2025-06
Intuitive Surgical USD 1.62B 160.2M 2025-06
Masimo USD 233.3M 700K 2025-06
Medtronic USD 5.12B 695M 2025-07
Philips EUR 2.01B 162M 2025-06
Ramsay Health Care AUD 6.32B 20.5M 2024-12
ResMed USD 827.92M 61.52M 2025-06
Sigma Healthcare AUD 160.13M 10.55M 2024-07
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Steris USD 628M 13.21M 2025-06
Teleflex USD 431.08M 41.65M 2025-06
Thermo Fisher Scientific USD 4.05B 260M 2025-06


ResMed سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Aug 2025.